The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
87855904 8785590 4 F 201106 20160830 20120914 20160906 PER US-ALEXION-A201201700 ALEXION 31.23 YR F Y 0.00000 20160906 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
87855904 8785590 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, SINGLE T2-A67765C 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
87855904 8785590 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, QW X 4 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
87855904 8785590 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W T2-A75446C 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
87855904 8785590 4 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Unknown UNK Y 0
87855904 8785590 5 C CIPROFLOXACIN. CIPROFLOXACIN 1 Unknown 250 MG, QD 41510.418 MG 0 250 MG QD
87855904 8785590 6 C TACROLIMUS. TACROLIMUS 1 Unknown UNK 0
87855904 8785590 7 C PREDNISONE. PREDNISONE 1 Unknown UNK 0
87855904 8785590 8 C METOPROLOL. METOPROLOL 1 Unknown UNK 0
87855904 8785590 9 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 Unknown 0
87855904 8785590 10 C MYCOPHENOLATE MYCOPHENOLIC ACID 1 Unknown UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
87855904 8785590 1 Haemolytic uraemic syndrome
87855904 8785590 4 Product used for unknown indication
87855904 8785590 5 Prophylaxis
87855904 8785590 6 Product used for unknown indication
87855904 8785590 7 Product used for unknown indication
87855904 8785590 8 Product used for unknown indication
87855904 8785590 9 Product used for unknown indication
87855904 8785590 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
87855904 8785590 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
87855904 8785590 Blood lactate dehydrogenase increased
87855904 8785590 Cytomegalovirus infection
87855904 8785590 Haemoglobin decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
87855904 8785590 1 201206 201206 0
87855904 8785590 2 201106 201107 0
87855904 8785590 3 201107 0
87855904 8785590 4 201208 0
87855904 8785590 5 20110623 20120801 0